EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Combining computational modeling and experimental library screening to affinity‐mature VEEV ‐neutralizing antibody F5

Christopher A Sumner iD, Jennifer L Schwedler, Katherine Maia McCoy iD, Jack Holland, Valerie Duva, Daniel Gelperin, Valeria Busygina, Maxwell A Stefan, Daniella V Martinez, Miranda A Juarros, Ashlee M Phillips, Dina R Weilhammer and 3 more

Protein Science · 2025

DOI: 10.1002/pro.70043 ↗

At a glance

Journal article in Protein Science, 2025. Written by Christopher A Sumner and 14 co-authors. Institution: Department of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, California, USA. Major MEDLINE topics: Antibodies, Neutralizing, Encephalitis Virus, Venezuelan Equine, Antibodies, Monoclonal, Antibodies, Viral. Cited 2 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Defense Threat Reduction Agency.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Engineered monoclonal antibodies have proven to be highly effective therapeutics in recent viral outbreaks. However, despite technical advancements, an ability to rapidly adapt or increase antibody affinity and by extension, therapeutic efficacy, has yet to be fully realized. We endeavored to stand‐up such a pipeline using molecular modeling combined with experimental library screening to increase the affinity of F5, a monoclonal antibody with potent neutralizing activity against Venezuelan Equine Encephalitis Virus (VEEV), to recombinant VEEV (IAB) E1E2 antigen. We modeled the F5/E1E2 binding interface and generated predictions for mutations to improve binding using a Rosetta‐based approach and dTERMen, an informatics approach. The modeling was complicated by the fact that a high‐resolution structure of F5 is not available and the H3 loop of F5 exceeds the length for which current modeling approaches can determine a unique structure. A subset of the predicted mutations from both methods were incorporated into a phage display library of scFvs. This library and a library generated by error‐prone PCR were screened for binding affinity to the recombinant antigen. Results from the screens identified favorable mutations which were incorporated into 12 human‐IgG1 variants. The best variant, containing eight mutations, improved KD from 0.63 nM (parental) to 0.01 nM. While this did not improve neutralization or therapeutic potency of F5 against IAB, it did increase cross‐reactivity to other closely related VEEV epizootic and enzootic strains, demonstrating the potential of this method to rapidly adapt existing therapeutics to emerging viral strains.

Subjects

MeSH terms (MEDLINE)

Antibodies, NeutralizingEncephalitis Virus, Venezuelan EquineAntibodies, MonoclonalAntibodies, ViralSingle-Chain AntibodiesModels, MolecularPeptide LibraryAntibody AffinityHumans

Author keywords

affinity‐maturationanti‐viralcomputational modelinglibrary screeningtherapeutic antibodies

Substances

Antibodies, NeutralizingAntibodies, MonoclonalPeptide LibraryAntibodies, ViralSingle-Chain Antibodies

Authors and institutions

  • Department of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, California, USA.
  • Department of Molecular and Cell Biology, Dartmouth College, Hanover, New Hampshire, USA.
  • Department of Computer Science, Dartmouth College, Hanover, New Hampshire, USA.
  • Abcam, Branford, Connecticut, USA.
  • Department of Molecular and Microbiology, Sandia National Laboratories, Albuquerque, New Mexico, USA.
  • Division of Biosciences and Biotechnology, Lawrence Livermore National Laboratories, Livermore, California, USA.

ORCID profiles: Christopher A Sumner, Katherine Maia McCoy, Gevorg Grigoryan, Michael S Kent

Funding

  • Defense Threat Reduction Agency

Cite

APA

Sumner, C. A., Schwedler, J. L., McCoy, K. M., Holland, J., Duva, V., Gelperin, D., Busygina, V., Stefan, M. A., Martinez, D. V., Juarros, M. A., Phillips, A. M., Weilhammer, D. R., Grigoryan, G., Kent, M. S., & Harmon, B. N. (2025). Combining computational modeling and experimental library screening to affinity‐mature VEEV ‐neutralizing antibody F5. Protein Science. https://doi.org/10.1002/pro.70043

Vancouver

Sumner CA, Schwedler JL, McCoy KM, Holland J, Duva V, Gelperin D, et al. Combining computational modeling and experimental library screening to affinity‐mature VEEV ‐neutralizing antibody F5. Protein Science. 2025. doi:10.1002/pro.70043

BibTeX
@article{Sumner2025,
  author = {Sumner, Christopher A and Schwedler, Jennifer L and McCoy, Katherine Maia and Holland, Jack and Duva, Valerie and Gelperin, Daniel and Busygina, Valeria and Stefan, Maxwell A and Martinez, Daniella V and Juarros, Miranda A and Phillips, Ashlee M and Weilhammer, Dina R and Grigoryan, Gevorg and Kent, Michael S and Harmon, Brooke N},
  title = {Combining computational modeling and experimental library screening to affinity‐mature VEEV ‐neutralizing antibody F5},
  journal = {Protein Science},
  year = {2025},
  doi = {10.1002/pro.70043}
}
Start for free →